Showing 1 - 7 results of 7 for search 'Michael K. Schultz', query time: 0.03s Refine Results
  1. 1
    Towards Effective Targeted Alpha Therapy for Neuroendocrine Tumours: A Review

    Towards Effective Targeted Alpha Therapy for Neuroendocrine Tumours: A Review by Paul M. D. Gape, Michael K. Schultz, Graeme J. Stasiuk, Samantha Y. A. Terry

    Published 2024-03-01
    Get full text
    Article
  2. 2
    Influence of the Molar Activity of <sup>203/212</sup>Pb-PSC-PEG<sub>2</sub>-TOC on Somatostatin Receptor Type 2-Binding and Cell Uptake

    Influence of the Molar Activity of <sup>203/212</sup>Pb-PSC-PEG<sub>2</sub>-TOC on Somatostatin Receptor Type 2-Binding and Cell Uptake by Marc Pretze, Enrico Michler, Roswitha Runge, Kerstin Wetzig, Katja Tietze, Florian Brandt, Michael K. Schultz, Jörg Kotzerke

    Published 2023-11-01
    Get full text
    Article
  3. 3
    Mitochondrial-Targeted Decyl-Triphenylphosphonium Enhances 2-Deoxy-D-Glucose Mediated Oxidative Stress and Clonogenic Killing of Multiple Myeloma Cells.

    Mitochondrial-Targeted Decyl-Triphenylphosphonium Enhances 2-Deoxy-D-Glucose Mediated Oxidative Stress and Clonogenic Killing of Multiple Myeloma Cells. by Jeanine Schibler, Ann M Tomanek-Chalkley, Jessica L Reedy, Fenghuang Zhan, Douglas R Spitz, Michael K Schultz, Apollina Goel

    Published 2016-01-01
    Get full text
    Article
  4. 4
    Targeted Alpha-Particle Radiotherapy and Immune Checkpoint Inhibitors Induces Cooperative Inhibition on Tumor Growth of Malignant Melanoma

    Targeted Alpha-Particle Radiotherapy and Immune Checkpoint Inhibitors Induces Cooperative Inhibition on Tumor Growth of Malignant Melanoma by Mengshi Li, Dijie Liu, Dongyoul Lee, Yinwen Cheng, Nicholas J. Baumhover, Brenna M. Marks, Edwin A. Sagastume, Zuhair K. Ballas, Frances L. Johnson, Zachary S. Morris, Michael K. Schultz

    Published 2021-07-01
    Get full text
    Article
  5. 5
    Dosimetry of [<sup>212</sup>Pb]VMT01, a MC1R-Targeted Alpha Therapeutic Compound, and Effect of Free <sup>208</sup>Tl on Tissue Absorbed Doses

    Dosimetry of [<sup>212</sup>Pb]VMT01, a MC1R-Targeted Alpha Therapeutic Compound, and Effect of Free <sup>208</sup>Tl on Tissue Absorbed Doses by Kelly D. Orcutt, Kelly E. Henry, Christine Habjan, Keryn Palmer, Jack Heimann, Julie M. Cupido, Vijay Gottumukkala, Derek D. Cissell, Morgan C. Lyon, Amira I. Hussein, Dijie Liu, Mengshi Li, Frances L. Johnson, Michael K. Schultz

    Published 2022-09-01
    Get full text
    Article
  6. 6
    Preclinical Evaluation of a Lead Specific Chelator (PSC) Conjugated to Radiopeptides for <sup>203</sup>Pb and <sup>212</sup>Pb-Based Theranostics

    Preclinical Evaluation of a Lead Specific Chelator (PSC) Conjugated to Radiopeptides for <sup>203</sup>Pb and <sup>212</sup>Pb-Based Theranostics by Mengshi Li, Nicholas J. Baumhover, Dijie Liu, Brianna S. Cagle, Frédéric Boschetti, Guillaume Paulin, Dongyoul Lee, Zhiming Dai, Ephraim R. Obot, Brenna M. Marks, Ibrahim Okeil, Edwin A. Sagastume, Moustafa Gabr, F. Christopher Pigge, Frances L. Johnson, Michael K. Schultz

    Published 2023-01-01
    Get full text
    Article
  7. 7
    Triphenylphosphonium derivatives disrupt metabolism and inhibit melanoma growth in vivo when delivered via a thermosensitive hydrogel.

    Triphenylphosphonium derivatives disrupt metabolism and inhibit melanoma growth in vivo when delivered via a thermosensitive hydrogel. by Kyle C Kloepping, Alora S Kraus, Devin K Hedlund, Colette M Gnade, Brett A Wagner, Michael L McCormick, Melissa A Fath, Dongrim Seol, Tae-Hong Lim, Garry R Buettner, Prabhat C Goswami, F Christopher Pigge, Douglas R Spitz, Michael K Schultz

    Published 2020-01-01
    Get full text
    Article

Search Tools: